NCT07629089 VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations Status NOT_YET_RECRUITING Phase PHASE1
NCT07628647 Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being Status NOT_YET_RECRUITING Phase NA
NCT07493447 Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures Status RECRUITING Phase EARLY_PHASE1
NCT07416188 Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT07398066 DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) Status NOT_YET_RECRUITING Phase NA
NCT07374692 Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors Status RECRUITING Phase NA
NCT07326566 Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII Status RECRUITING Phase PHASE2
NCT07313709 Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors. Status NOT_YET_RECRUITING Phase NA
NCT07307157 Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review Status ENROLLING_BY_INVITATION Phase N/A
NCT07210632 Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) Status RECRUITING Phase EARLY_PHASE1
NCT06991101 Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma Status RECRUITING Phase PHASE2
NCT06930846 HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) Status RECRUITING Phase NA
NCT06640582 TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas Status RECRUITING Phase PHASE1/PHASE2
NCT06582849 Enhanced Assistance During Radiotherapy for Unmet Essential Needs Status COMPLETED Phase NA
NCT06580002 Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial Status RECRUITING Phase PHASE2
NCT06322342 Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent Status COMPLETED Phase PHASE2
NCT06168825 Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention Status COMPLETED Phase N/A